Biomea Fusion, Inc. (BMEA) vs Cardiff Oncology, Inc. (CRDF)
A side-by-side comparison of Biomea Fusion, Inc. and Cardiff Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMEA
Biomea Fusion, Inc.
$1.30HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CRDF
Cardiff Oncology, Inc.
$1.14HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BMEA vs CRDF
growth of $100 · dividends reinvested · last 5yBMEA -92.4% (-40.2%/yr)CRDF -87.3% (-33.8%/yr)CRDF compounded faster over this window
BMEA CRDF
BMEA vs CRDF: by the numbers
- •BMEA is the larger company ($94M vs $88M market cap).
- •Both run net losses; BMEA's is the smaller (0.00% vs -7884.06% net margin).
Metrics side by side
Valuation
| Metric | BMEA | CRDF |
|---|---|---|
| P/S ratio | N/A | 172.96 |
| P/B ratio | 7.74 | 3.31 |
Profitability
| Metric | BMEA | CRDF |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -8256.32% |
| Net margin | 0.00% | -7884.06% |
| ROE | -268.09% | -150.95% |
| ROIC | -220.02% | -159.30% |
Growth (annualized)
| Metric | BMEA | CRDF |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.15% |
| Total return CAGR (5Y) | -36.56% | -30.36% |
Frequently asked
- How have BMEA and CRDF total returns compared?
- Over the past 5 years, BMEA delivered -36.56% and CRDF delivered -30.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.